TITLE

Beta-blockers in hypertension

AUTHOR(S)
Wilkinson, J. C.
PUB. DATE
December 1970
SOURCE
British Medical Journal;12/26/1970, Vol. 4 Issue 5738, p802
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64098853

 

Related Articles

  • Betting on Beta-Blockers. Wetherbee, Kris // Town & Country;Dec2001, Vol. 155 Issue 5259, p160 

    Details the role of beta-blockers in preventing hypertension.

  • Antiypertensive treatment with beta-blockers in patients aged over 65. Wilkstrand, John; Berglund, Goran // British Medical Journal (Clinical Research Edition);9/25/1982, Vol. 285 Issue 6345, p850 

    Examines the use of beta-blockers in elderly patients with hypertension. Diagnosis of dyspnoea on exertion as a heart failure; Groups of beta-blocker medication; Effects of beta-blockers on diastolic filling.

  • Beta-blocker therapy in an infant with pulmonary hypertension. Buchhorn, R.; Hulpke-Wette, M.; Wessel, A.; Bürsch, J.; Bürsch, J // European Journal of Pediatrics;1999, Vol. 158 Issue 12, p1007 

    Discusses the use of beta-blocker therapy in an infant with pulmonary hypertension. Description of primary pulmonary hypertension; Hemodynamic and neurohormonal data of the patient; Effectiveness of the beta-blocker therapy in protecting the myocardium against toxic norepinephrine levels.

  • Beta-blockers: When, which one, and why. Cheitlin, Melvin D.; Frishman, William H. // Patient Care;8/15/1993, Vol. 27 Issue 13, p21 

    Presents guidelines in prescribing beta-blockers for cardiovascular diseases. Patient selection as a critical factor in giving beta-blockers for hypertension; Beta-blockers for angina; Benefits during myocardial infarction and ischemia. INSET: Cardiopulmonary risks of beta-blockers..

  • Should every survivor of a heat attack be given a beta-blocker? Hampton, J.R.; Breckenridge, A.; Rose, Geoffrey // British Medical Journal (Clinical Research Edition);7/3/1982, Vol. 285 Issue 6334, p33 

    Part I, II and III. Focuses on the use of a beta-blocker in survivor of heart attack in Great Britain. Difficulty to use beta-blockers in the initial stages of a heart attack; Reduction of mortality in patients treated with beta-blockers; Administration of beta-blockers in patients due to...

  • Untitled. O'Callaghan, Tiffany // Time;4/26/2010, Vol. 175 Issue 16, p35 

    The article discusses epidemiological findings on the mortality of female breast cancer patients as correlated with their use of beta-blocker drugs for hypertension.

  • nebivolol.  // Royal Society of Medicine: Medicines;2002, p386 

    This article presents information on beta-blocker nebivolol. It is a vasolidator which can be used as treatment for hypertension. It is administered orally.

  • HYPERTENSION: BETA-BLOCKER PHARMACOKINETICS.  // Monthly Prescribing Reference;Dec2014, Vol. 30 Issue 12, p31 

    A table is presented which provides information on beta-blocker pharmacokinetics for hypertension medicine including acebutolol, atenolol, and betaxolol.

  • Effects of Atenolol and Propranolol on Platelet Aggregation in Moderate Essential Hypertension: Randomized Crossover Trial. Punda, Ante; Polić, Stojan; Rumboldt, Zvonko; Bagatin, Jugoslav; Marković, Vinko; Lukin, Ajvor // Croatian Medical Journal;2005, Vol. 46 Issue 2, p219 

    Compares the effects of a selective beta-blocker atenolol and a nonselective beta-blocker propanolol on platelet aggregation. Role of platelet aggregation and arterial hypertension in the development of atherosclerosis; Methodology of the study; Discussion on the results of the study.

  • Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. Wilcox, R.G. // British Medical Journal;8/5/1978, Vol. 2 Issue 6134, p383 

    Examines the effectiveness of beta-blockers and thiazide diuretic in the treatment of essential hypertension. Assessment of incidence of drug side effects; Evaluation of standing blood pressure after treatment; Major disadvantage of the use of beta-blockers.

Share

Other Topics